Overview:

In recent years, the applicability of novel therapies in the management of acute myeloid leukemia (AML) has expanded dramatically, offering new opportunities to achieve disease control in select patients. However, this has also increased the demands on healthcare professionals to keep pace with a rapidly expanding arsenal of treatment options. In particular, adequate testing, treatment selection, and management of adverse events has continued to evolve at a rapid pace.

This meeting series is designed in conjunction with expert faculty in the management of AML to distill the evolving best practices for a community of oncology professionals who treat many different forms of cancer. It will feature key updates from clinical trials, supplemented by illustrative case presentations presented by community oncology moderators. Audience members will also have the opportunity to pose their questions on management of AML to the expert faculty in real time.

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Implement personalized care plans for patients with AML aligned with guideline-recommended molecular testing and risk stratification protocols
• Assess emerging strategies for the management of patients with AML in the frontline, maintenance and relapsed/refractory setting
• Devise effective strategies to monitor for and manage treatment-associated adverse events in patients with AML.

Target Audience:

This educational program is primarily directed toward community-based medical oncologists/hematologists, oncology nurses, advanced practice providers, and other healthcare professionals involved in the treatment of AML.

Accreditation/Credit Designation:

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.25 Contact Hours. 

Acknowledgment of Educational Support

This activity is supported by educational grants from Kura Oncology, Inc., and Rigel Pharmaceuticals, Inc.

Have a question for the PER® team?

Oncology Inquiries: onc-info@gotoper.com

Eye Care Inquiries: eye-info@gotoper.com

Multispecialty Inquiries: multi-info@gotoper.com